Cecilia A. Asnal
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Recommendations of the Argentine Society of Rheumatology for the Treatment of Patients With Rheumatoid Arthritis: 2025 Update Part I.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: March 11, 2026
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial.
Journal: Rheumatology and therapy
Published: November 28, 2023
Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.
Journal: Clinical rheumatology
Published: June 15, 2022
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study.
Journal: Rheumatology (Oxford, England)
Published: June 01, 2022
Primary Sjögren syndrome and development of another autoimmune rheumatic disease during the follow-up.
Journal: Advances in rheumatology (London, England)
Published: January 11, 2022
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial.
Journal: Annals of the rheumatic diseases
Published: June 24, 2021
Work productivity and activity impairment in patients with primary Sjögren's syndrome.
Journal: Clinical and experimental rheumatology
Published: June 14, 2021
Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
Journal: Clinical rheumatology
Published: May 09, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026